Analysis of progression-free survival, tolerability and toxicity in patients with stage III ovarian, tubal and peritoneal carcinoma treated with an outpatient regimen of primary intravenous/intraperitoneal paclitaxel and intraperitoneal cisplatin Meeting Abstract

  

Authors:	Chi, D.; Dao, F.; Ferguson, S.; Sabbatini, P.; Hensley, M.; Konner, J.; Tew, W.; Bell-Mcguinn, K.; Barakat, R.; Aghajanian, C.
Abstract Title:	Analysis of progression-free survival, tolerability and toxicity in patients with stage III ovarian, tubal and peritoneal carcinoma treated with an outpatient regimen of primary intravenous/intraperitoneal paclitaxel and intraperitoneal cisplatin
Meeting Title:	41st Annual Meeting of the Society of Gynecologic Oncologists (SGO)
Journal Title:	Gynecologic Oncology
Volume:	116
Issue:	3 Suppl.
Meeting Dates:	2010 Mar 14-17
Meeting Location:	San Francisco, CA
ISSN:	0090-8258
Publisher:	Elsevier Inc.
Date Published:	2010-03-01
Start Page:	S123
Language:	English
ACCESSION:	ISI:000277538000304
PROVIDER:	wos
PUBMED:	20171349
DOI:	10.1016/j.ygyno.2009.12.013
Notes:	- Meeting Abstract: 313 - "Source: Wos"

https://synapse.mskcc.org/synapse/works/has_related_data_chk/6442